Indivior ( (GB:INDV) ) has provided an update.
Indivior PLC has announced a change in the interests of its Chief Executive Officer, Mark Crossley, involving a Conditional Award of 9,375 Ordinary Shares under the Indivior Deferred Bonus Plan 2018. This award is part of the deferral of 25% of the gross bonus earned under the Indivior 2024 Annual Incentive Plan, set to vest on the second anniversary of the award date, contingent upon continued employment. This notification complies with the UK Market Abuse Regulation, reflecting the company’s adherence to regulatory requirements and its commitment to transparent executive compensation practices.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing on the development and commercialization of medications for the treatment of addiction and related mental health disorders. The company is known for its products that address opioid dependence and other substance use disorders, positioning itself as a leader in addiction treatment solutions.
YTD Price Performance: -28.08%
Average Trading Volume: 336,789
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £934.3M
See more insights into INDV stock on TipRanks’ Stock Analysis page.